Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: E9ACR1
Term | Name | Level | Count |
---|---|---|---|
GO:0008152 | metabolic process | 1 | 1 |
GO:0032259 | methylation | 2 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0008168 | methyltransferase activity | 4 | 1 |
GO:0016740 | transferase activity | 2 | 1 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 243 | 245 | PF00675 | 0.415 |
CLV_NRD_NRD_1 | 95 | 97 | PF00675 | 0.392 |
CLV_PCSK_KEX2_1 | 186 | 188 | PF00082 | 0.411 |
CLV_PCSK_KEX2_1 | 243 | 245 | PF00082 | 0.388 |
CLV_PCSK_KEX2_1 | 95 | 97 | PF00082 | 0.441 |
CLV_PCSK_PC1ET2_1 | 186 | 188 | PF00082 | 0.411 |
CLV_PCSK_PC1ET2_1 | 243 | 245 | PF00082 | 0.388 |
CLV_PCSK_SKI1_1 | 49 | 53 | PF00082 | 0.571 |
DEG_MDM2_SWIB_1 | 167 | 174 | PF02201 | 0.445 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.638 |
DOC_CYCLIN_yCln2_LP_2 | 160 | 166 | PF00134 | 0.411 |
DOC_MAPK_MEF2A_6 | 17 | 26 | PF00069 | 0.514 |
DOC_MAPK_MEF2A_6 | 175 | 184 | PF00069 | 0.399 |
DOC_USP7_MATH_1 | 20 | 24 | PF00917 | 0.530 |
DOC_WD40_RPTOR_TOS_1 | 125 | 131 | PF00400 | 0.314 |
DOC_WW_Pin1_4 | 18 | 23 | PF00397 | 0.538 |
DOC_WW_Pin1_4 | 94 | 99 | PF00397 | 0.467 |
LIG_14-3-3_CanoR_1 | 232 | 241 | PF00244 | 0.548 |
LIG_BRCT_BRCA1_1 | 41 | 45 | PF00533 | 0.460 |
LIG_FHA_1 | 152 | 158 | PF00498 | 0.411 |
LIG_FHA_1 | 183 | 189 | PF00498 | 0.411 |
LIG_FHA_1 | 229 | 235 | PF00498 | 0.518 |
LIG_FHA_2 | 150 | 156 | PF00498 | 0.411 |
LIG_LIR_Apic_2 | 131 | 136 | PF02991 | 0.405 |
LIG_LIR_Gen_1 | 146 | 156 | PF02991 | 0.514 |
LIG_LIR_Gen_1 | 169 | 176 | PF02991 | 0.357 |
LIG_LIR_Gen_1 | 212 | 223 | PF02991 | 0.410 |
LIG_LIR_Gen_1 | 70 | 81 | PF02991 | 0.354 |
LIG_LIR_Nem_3 | 128 | 133 | PF02991 | 0.411 |
LIG_LIR_Nem_3 | 146 | 151 | PF02991 | 0.411 |
LIG_LIR_Nem_3 | 165 | 170 | PF02991 | 0.426 |
LIG_LIR_Nem_3 | 212 | 218 | PF02991 | 0.410 |
LIG_LIR_Nem_3 | 70 | 76 | PF02991 | 0.354 |
LIG_Pex14_2 | 167 | 171 | PF04695 | 0.483 |
LIG_PTB_Apo_2 | 194 | 201 | PF02174 | 0.411 |
LIG_PTB_Phospho_1 | 194 | 200 | PF10480 | 0.411 |
LIG_SH2_CRK | 148 | 152 | PF00017 | 0.411 |
LIG_SH2_STAP1 | 73 | 77 | PF00017 | 0.411 |
LIG_SH2_STAT3 | 99 | 102 | PF00017 | 0.314 |
LIG_SH2_STAT5 | 134 | 137 | PF00017 | 0.352 |
LIG_SH2_STAT5 | 140 | 143 | PF00017 | 0.352 |
LIG_SH2_STAT5 | 200 | 203 | PF00017 | 0.411 |
LIG_SH2_STAT5 | 87 | 90 | PF00017 | 0.393 |
LIG_SH3_1 | 95 | 101 | PF00018 | 0.380 |
LIG_SH3_3 | 41 | 47 | PF00018 | 0.427 |
LIG_SH3_3 | 95 | 101 | PF00018 | 0.504 |
LIG_SH3_5 | 83 | 87 | PF00018 | 0.445 |
LIG_SUMO_SIM_anti_2 | 237 | 242 | PF11976 | 0.432 |
LIG_SUMO_SIM_par_1 | 179 | 185 | PF11976 | 0.399 |
LIG_TRAF2_1 | 54 | 57 | PF00917 | 0.528 |
MOD_CK1_1 | 221 | 227 | PF00069 | 0.528 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.617 |
MOD_CK1_1 | 94 | 100 | PF00069 | 0.294 |
MOD_CK2_1 | 149 | 155 | PF00069 | 0.371 |
MOD_CK2_1 | 221 | 227 | PF00069 | 0.444 |
MOD_CK2_1 | 50 | 56 | PF00069 | 0.517 |
MOD_GlcNHglycan | 118 | 121 | PF01048 | 0.393 |
MOD_GlcNHglycan | 234 | 237 | PF01048 | 0.546 |
MOD_GlcNHglycan | 53 | 56 | PF01048 | 0.468 |
MOD_GlcNHglycan | 88 | 91 | PF01048 | 0.358 |
MOD_GSK3_1 | 162 | 169 | PF00069 | 0.415 |
MOD_GSK3_1 | 18 | 25 | PF00069 | 0.512 |
MOD_GSK3_1 | 198 | 205 | PF00069 | 0.501 |
MOD_GSK3_1 | 221 | 228 | PF00069 | 0.528 |
MOD_N-GLC_1 | 123 | 128 | PF02516 | 0.423 |
MOD_N-GLC_1 | 91 | 96 | PF02516 | 0.314 |
MOD_N-GLC_2 | 14 | 16 | PF02516 | 0.475 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.630 |
MOD_NEK2_1 | 170 | 175 | PF00069 | 0.347 |
MOD_NEK2_1 | 209 | 214 | PF00069 | 0.445 |
MOD_NEK2_1 | 218 | 223 | PF00069 | 0.364 |
MOD_NEK2_1 | 50 | 55 | PF00069 | 0.483 |
MOD_NEK2_2 | 22 | 27 | PF00069 | 0.524 |
MOD_Plk_1 | 1 | 7 | PF00069 | 0.636 |
MOD_Plk_1 | 123 | 129 | PF00069 | 0.522 |
MOD_Plk_4 | 162 | 168 | PF00069 | 0.445 |
MOD_Plk_4 | 22 | 28 | PF00069 | 0.577 |
MOD_Plk_4 | 39 | 45 | PF00069 | 0.259 |
MOD_ProDKin_1 | 18 | 24 | PF00069 | 0.535 |
MOD_ProDKin_1 | 94 | 100 | PF00069 | 0.467 |
MOD_SUMO_rev_2 | 53 | 60 | PF00179 | 0.495 |
TRG_DiLeu_BaEn_2 | 145 | 151 | PF01217 | 0.405 |
TRG_ENDOCYTIC_2 | 148 | 151 | PF00928 | 0.515 |
TRG_ENDOCYTIC_2 | 73 | 76 | PF00928 | 0.411 |
TRG_ER_diLys_1 | 243 | 248 | PF00400 | 0.479 |
TRG_ER_FFAT_2 | 146 | 155 | PF00635 | 0.501 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDF1 | Leptomonas seymouri | 59% | 100% |
A0A3S7WRE9 | Leishmania donovani | 89% | 80% |
A4H6B4 | Leishmania braziliensis | 72% | 100% |
A4HUN7 | Leishmania infantum | 91% | 100% |
E9AND6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |